SCHEMBL6962855

SCHEMBL6962855

CCOC(=O)OC1=C(C2CC2)NC(C2CC2)=C(OC(=O)OCC)C1c1ccc(F)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPK1 P28482 1/20 0.41
ACHE P22303 1/20 0.41
CACNA1F O60840 1/20 0.40
CACNA1D Q01668 1/20 0.40
CACNA1S Q13698 1/20 0.40
CACNA1C Q13936 1/20 0.40
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 3/20 0.40
LMNA P02545 2/20 0.40
HSD17B10 Q99714 2/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 1/20 0.40
POLB P06746 1/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6956368 0.90 CACNA1F (0.40) HTTMEN1KMT2AMAPK1ACHE
SCHEMBL9369030 0.83 CACNA1F (0.49) HTTMEN1KMT2AACHECACNA1F
SCHEMBL8949928 0.82 KDM4E (0.53) MEN1KMT2AACHECACNA1FCACNA1D
SCHEMBL9367591 0.81 HTT (0.40) HTTMEN1KMT2AMAPK1ACHE
SCHEMBL6949791 0.79 CACNA1F (0.46) HTTMEN1KMT2AACHECACNA1F
SCHEMBL9363815 0.78 NPSR1 (0.48) HTTMEN1KMT2AMAPK1ACHE
SCHEMBL9359818 0.74 CACNA1F (0.42) HTTACHECACNA1FCACNA1DCACNA1S
SCHEMBL8949606 0.73 CACNA1F (0.48) MEN1KMT2AACHECACNA1FCACNA1D
SCHEMBL9363639 0.73 CACNA1D (0.41) HTTMAPK1ACHECACNA1FCACNA1D
SCHEMBL9359615 0.71 CACNA1F (0.40) HTTACHECACNA1FCACNA1DCACNA1S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0325130-B1 Substituted pyridines BAYER AG (DE) 2003-11-05 EP disclosed
EP-1123924-A1 Substituted pyridines as HMG-COA reductase inhibitors BAYER AG (DE) 2001-08-16 EP disclosed
EP-1123925-A1 Process for preparation of substituted pyridines BAYER AG (DE) 2001-08-16 EP disclosed
EP-0325129-B1 Disubstituted pyridines BAYER AG (DE) 1994-09-07 EP disclosed
EP-0325129-A2 Disubstituted pyridines BAYER AG (DE) 1989-07-26 EP disclosed
EP-0325130-A2 Substituted pyridines BAYER AG (DE) 1989-07-26 EP disclosed